Tramadol

Generic Name
Tramadol
Brand Names
Conzip, Durela, Qdolo, Ralivia, Ryzolt, Seglentis, Tridural, Ultracet, Ultram, Zytram
Drug Type
Small Molecule
Chemical Formula
C16H25NO2
CAS Number
27203-92-5
Unique Ingredient Identifier
39J1LGJ30J
Background

Tramadol is a centrally acting synthetic opioid analgesic and SNRI (serotonin/norepinephrine reuptake-inhibitor) that is structurally related to codeine and morphine. Due to its good tolerability profile and multimodal mechanism of action, tramadol is generally considered a lower-risk opioid option for the treatment of moderate to severe pain. It is considered a Step 2 option on the World Health Organization's pain ladder and has about 1/10th of the potency of morphine.

Tramadol differs from other traditional opioid medications in that it doesn't just act as a μ-opioid agonist, but also affects monoamines by modulating the effects of neurotransmitters involved in the modulation of pain such as serotonin and norepinpehrine which activate descending pain inhibitory pathways. Tramadol's effects on serotonin and norepinephrine mimic the effects of other SNRI antidepressants such as duloxetine and venlafaxine.

Tramadol exists as a racemic mixture consisting of two pharmacologically active enantiomers that both contribute to its analgesic property through different mechanisms and are also themselves metabolized into active metabolites: (+)-tramadol and its primary metabolite (+)-O-desmethyl-tramadol (M1) are agonists of the μ opioid receptor while (+)-tramadol inhibits serotonin reuptake and (-)-tramadol inhibits norepinephrine reuptake. These pathways are complementary and synergistic, improving tramadol's ability to modulate the perception of and response to pain.

Tramadol has also been shown to affect a number of other pain modulators within the central nervous system as well as non-neuronal inflammatory markers and immune mediators. Due to the broad spectrum of targets involved in pain and inflammation, it's not surprising that the evidence has shown that tramadol is effective for a number of pain types including neuropathic pain, post-operative pain, lower back pain, as well as pain associated with labour, osteoarthritis, fibromyalgia, and cancer. Due to its SNRI activity, tramadol also has anxiolytic, antidepressant, and anti-shivering effects which are all frequently found as comorbidities with pain.

Similar to other opioid medications, tramadol poses a risk for development of tolerance, dependence and abuse. If used in higher doses, or with other opioids, there is a dose-related risk of overdose, respiratory depression, and death. However, unlike other opioid medications, tramadol use also carries a risk of seizure and serotonin syndrome, particularly if used with other serotonergic medications.

Indication

Tramadol is approved for the management of moderate to severe pain in adults.

Tramadol is also used off-label in the treatment of premature ejaculation.

Associated Conditions
Acute Pain, Premature Ejaculation, Severe Pain, Acute, moderate, severe Pain, Moderate Pain
Associated Therapies
-

Tramadol Versus Diclofenac for Reducing Pain Before Outpatient Hysteroscopy

First Posted Date
2015-04-17
Last Posted Date
2017-01-23
Lead Sponsor
Cairo University
Target Recruit Count
210
Registration Number
NCT02419651
Locations
🇪🇬

Cairo University Hospitals, Cairo, Egypt

Postoperative Analgesia With Buprenorphine for Postoperative Pain Control and Quality of Life After Spinal Surgery

First Posted Date
2015-04-15
Last Posted Date
2017-05-03
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
69
Registration Number
NCT02416804
Locations
🇰🇷

Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Korea, Republic of

Ultrasound-guided Rectus Sheath Block In Children

First Posted Date
2014-11-14
Last Posted Date
2023-06-01
Lead Sponsor
Cukurova University
Target Recruit Count
40
Registration Number
NCT02291705
Locations
🇹🇷

Cukurova University, Adana, Turkey

Efficacy of Extended-release, Once Daily Tramadol for Post Operative Analgesia in Shoulder Arthroscopy

Phase 2
Terminated
Conditions
Interventions
First Posted Date
2014-09-25
Last Posted Date
2020-07-24
Lead Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Target Recruit Count
100
Registration Number
NCT02247648
Locations
🇨🇦

Institut de chirurgie spécialisée de Montréal, Montréal, Quebec, Canada

Intravenous Paracetamol for Postoperative Pain

First Posted Date
2014-09-25
Last Posted Date
2017-03-06
Lead Sponsor
Lithuanian University of Health Sciences
Target Recruit Count
54
Registration Number
NCT02248493
Locations
🇱🇹

Lithuanian University of Health Sciences Kaunas Clinics, Kaunas, Lithuania

Omnitram Pharmacokinetic Study In Healthy Volunteers

Phase 1
Completed
Conditions
Interventions
First Posted Date
2014-07-31
Last Posted Date
2014-10-15
Lead Sponsor
Syntrix Biosystems, Inc.
Target Recruit Count
43
Registration Number
NCT02205554
Locations
🇺🇸

CRI Lifetree Research Center, Salt Lake City, Utah, United States

© Copyright 2024. All Rights Reserved by MedPath